Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 12 of 39

  1. Dupilumab

    Regeneron UK Limited

    Dermatitis, Atopic

    approved small molecule active

    5 trials

  2. Dupilumab

    Regeneron UK Limited

    Atopic Dermatitis (AD)

    approved small molecule terminated

    2 trials

  3. Dupilumab

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    16 trials

  4. Dupilumab

    Regeneron UK Limited

    Dermal Hypersensitivity Reaction

    approved small molecule completed

    1 trial

  5. Dupilumab

    Regeneron UK Limited

    Eosinophilic Esophagitis

    approved small molecule active

    4 trials

  6. Dupilumab

    Regeneron UK Limited

    Moderate-to-Severe Atopic Dermatitis

    approved small molecule completed

    2 trials

  7. Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]

    Regeneron UK Limited

    Eosinophilic Esophagitis (EoE)

    approved small molecule active

    1 trial

  8. Dupilumab Injectable Product

    Regeneron UK Limited

    Asthma

    approved small molecule active

    1 trial

  9. Dupilumab Only Product

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    1 trial

  10. Dupilumab Prefilled Syringe

    Regeneron UK Limited

    Nasal Polyps

    approved small molecule active

    1 trial

  11. Dupilumab SAR231893

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule completed

    1 trial

  12. Dupilumab SAR231893

    Regeneron UK Limited

    Chronic Rhinosinusitis With Nasal Polyps

    approved small molecule completed

    1 trial

  13. Dupilumab SAR231893

    Regeneron UK Limited

    Dermatitis Atopic

    approved small molecule completed

    2 trials

  14. Dupixent

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    1 trial

  15. Duragesic reference fentanyl TDS

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  16. Durvalumab

    AstraZeneca

    Solid Tumor

    approved small molecule completed

    1 trial

  17. Dutasteride plus tamsulosin

    GlaxoSmithKline

    Prostatic Hyperplasia

    approved small molecule completed

    1 trial

  18. Dynepo

    Takeda

    Anemia

    approved small molecule terminated

    1 trial

  19. EASYlight-NEK

    Shanghai Reinovax Biologics Co.,LTD

    Endometriosis

    approved small molecule active

    1 trial

  20. EC-120888

    CERO THERAPEUTICS HOLDINGS, INC.

    Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)

    approved small molecule active

    1 trial

  21. EC/2013/472

    Takeda

    Prostate or Bladder Cancer

    approved small molecule completed

    1 trial

  22. EFFI2021/01

    Italfarmaco S.p.A.

    Female contraception.

    approved small molecule active

    1 trial

  23. ELAPRASE

    Takeda

    Mucopolysaccharidosis (MPS)

    approved small molecule terminated

    1 trial

  24. ELEVIDYS

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial

  25. ENDORET-PRGF

    The George Institute

    pterygium

    approved small molecule active

    1 trial

  26. ENRICH-AF

    The George Institute

    High risk atrial fibrillation patients with previous intracranial hemorrhage

    approved small molecule active

    1 trial

  27. EPHIC-DIA2

    The George Institute

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  28. EPIAO®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anaemia

    approved small molecule terminated

    1 trial

  29. ESOMEPRAZOLE, ESOMEPRAZOLE

    Fondazione Telethon ETS

    obesity

    approved small molecule active

    1 trial

  30. ESTECLIN 300 MG CAPSULE RIGIDE

    Zafatek

    COPD

    approved small molecule active

    1 trial

  31. ETHINYL ESTRADIOL AND LEVOGESTREL

    United Therapeutics Europe Ltd

    HIV/AIDS

    approved small molecule completed

    1 trial

  32. ETN Alone

    Universal Integrated

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial

  33. EUS-guided pancreatic pseudocyst drainage

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Pseudocyst

    approved other active

    1 trial

  34. EV71 Vaccine

    Sinovac Research and Development Co.,

    EV71 Vaccine

    approved mab completed

    1 trial

  35. EV71 Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial

  36. EV71 inactived vaccine（Vero cells）

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  37. EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  38. EVOLOCUMAB

    Amgen

    Dyslipidemia

    approved small molecule active

    1 trial

  39. EXPAREL

    Pacira Ireland Limited

    Obesity

    approved small molecule completed

    1 trial

  40. EXPAREL

    Pacira Ireland Limited

    Hernia

    approved small molecule completed

    1 trial

  41. EXPAREL

    Pacira Ireland Limited

    Postoperative Pain

    approved small molecule active

    2 trials

  42. EXPAREL

    Pacira Ireland Limited

    Pain

    approved small molecule completed

    4 trials

  43. EXPAREL

    Pacira Ireland Limited

    Hip Fractures

    approved small molecule terminated

    1 trial

  44. EXPAREL 1.3 % in 20 ML Injection

    Pacira Ireland Limited

    Rotator Cuff Tear

    approved small molecule terminated

    1 trial

  45. EXPAREL 20 mL

    Pacira Ireland Limited

    Postsurgical Pain

    approved small molecule completed

    1 trial

  46. EXPAREL and Bupivacaine

    Pacira Ireland Limited

    Postoperative Pain Management

    approved small molecule terminated

    1 trial

  47. EXPAREL and bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain Management

    approved small molecule terminated

    1 trial

  48. Echocardiographic guidance

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aortic Stenosis

    approved other active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.